ACET

ACET

USD

Adicet Bio Inc. Common Stock

$0.670+0.040 (6.349%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$0.630

High

$0.695

Low

$0.630

Volume

0.02M

Company Fundamentals

Market Cap

55.4M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.84M

Exchange

NGM

Currency

USD

52-Week Range

Low $0.447Current $0.670High $1.865

Related News

BusinessWire

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards

View more
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BusinessWire

Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the acceptance of an abstract

View more
Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
BusinessWire

Adicet Bio Appoints Michael Grissinger to the Board of Directors

--Mr. Grissinger brings more than four decades of leadership experience in pharmaceutical business development and strategic transactions-- Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company

View more
Adicet Bio Appoints Michael Grissinger to the Board of Directors